Francis Y Yao
Overview
Explore the profile of Francis Y Yao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
2573
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Norman J, Li P, Kotwani P, Yao F, Pham S, Gamez J, et al.
Liver Transpl
. 2024 Dec;
PMID: 39661334
The RETREAT (Risk Estimation of Tumor Recurrence After Transplant) Score is a validated tool to predict post-transplant HCC recurrence risk. Alpha-fetoprotein (AFP) bound to Lens culinaris agglutinin (AFP-L3) and des-gamma-carboxyprothrombin...
2.
Natarajan B, Tabrizian P, Hoteit M, Frenette C, Parikh N, Ghaziani T, et al.
Am J Transplant
. 2023 Aug;
23(11):1771-1780.
PMID: 37532179
Patients with hepatocellular carcinoma meeting united network for organ sharing (UNOS)-downstaging (DS) criteria have excellent liver transplantation (LT) outcomes after DS. However, outcomes for "all-comers" (AC) patients with tumors initially...
3.
Mehta N, Kelley R, Yao F
Hepatology
. 2023 May;
80(1):238-253.
PMID: 37183865
No abstract available.
4.
Mehta N, Kotwani P, Norman J, Shui A, Li P, Saxena V, et al.
Liver Transpl
. 2023 May;
29(10):1041-1049.
PMID: 37159217
In patients with HCC awaiting liver transplantation (LT), there is a need to identify biomarkers that are superior to AFP in predicting prognosis. AFP-L3 and des-gamma-carboxyprothrombin (DCP) play a role...
5.
Huang A, Dodge J, Yao F, Mehta N
Clin Gastroenterol Hepatol
. 2022 Aug;
21(6):1581-1589.
PMID: 36038129
Background & Aims: The United Network for Organ Sharing (UNOS) grants priority listing for liver transplant for patients with hepatocellular carcinoma after successful down-staging to Milan criteria. We evaluated the...
6.
Giard J, Dodge J, Yao F, Mehta N
Liver Transpl
. 2022 Jul;
29(2):233-235.
PMID: 35809249
No abstract available.
7.
Silverstein J, Yao F, Grab J, Braun H, Roberts J, Dodge J, et al.
Liver Transpl
. 2022 Feb;
28(7):1144-1157.
PMID: 35226793
Living donor liver transplantation (LDLT) is an attractive option to decrease waitlist dropout, particularly for patients with hepatocellular carcinoma (HCC) who face lengthening waiting times. Using the United Network for...
8.
Bernards S, Hirose R, Yao F, Jin C, Dodge J, Huang C, et al.
Liver Transpl
. 2021 Nov;
28(3):376-385.
PMID: 34761847
As a result of ongoing regional disparities, the United Network for Organ Sharing (UNOS) implemented policy in May 2019 limiting exception points for waitlisted patients with hepatocellular carcinoma (HCC) to...
9.
10.
Mehta N, Frenette C, Tabrizian P, Hoteit M, Guy J, Parikh N, et al.
Gastroenterology
. 2021 Jul;
161(5):1502-1512.
PMID: 34331914
Background & Aims: United Network of Organ Sharing (UNOS) has adopted uniform criteria for downstaging (UNOS-DS) of hepatocellular carcinoma (HCC) before liver transplantation (LT), but the downstaging success rate and...